Clinical Trial Update: Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant [Phase 4]

View source ↗

Summary

Phase 4 trial update on sofosbuvir-based direct-acting antiviral therapy for HIV/HCV coinfected patients before or after liver transplant; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• sofosbuvir-based direct-acting antiviral therapy (sofosbuvir)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV, Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2021-02-02